Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer

Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer

Abstract Backgrounds Overexpression of epidermal growth factor receptor (EGFR) has been established as a valid therapeutic target of non-small cell lung cancer (NSCLC). However, the clinical benefit of cetuximab as an EGFR-targeting drug is still controversial, partially due to the lack of effective...

Full description

Bibliographic Details
Main Authors: Aiko Yamaguchi, Arifudin Achmad, Hirofumi Hanaoka, Yusri Dwi Heryanto, Anu Bhattarai, Ratianto, Erdene Khongorzul, Rini Shintawati, A. Adhipatria P. Kartamihardja, Ayaka Kanai, Yumi Sugo, Noriko S. Ishioka, Tetsuya Higuchi, Yoshito Tsushima
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Cancer
Subjects:
Immuno-PET
Non-small cell lung cancer
Cetuximab
64Cu
Personalized medicine
EGFR
Online Access:http://link.springer.com/article/10.1186/s12885-019-6238-4

Internet

http://link.springer.com/article/10.1186/s12885-019-6238-4

Similar Items